NCT02715596

Changes in Body Composition After EPA Supplementation in Head and Neck Patients

Relationship Between Changes in Body Composition and Supplementation With EPA in Patients Diagnosed With Squamous Cell Carcinoma of Head and Neck Locally Advanced (Stage III-IVb)

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 54 (actual)
• Sponsor: Institut Català d'Oncologia · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Evaluates the effect of EPA supplementation in terms of muscle mass in patients with squamous cell carcinoma of the head and neck locally advanced

Detailed description

This study is designed to evaluate the effect of EPA supplementation on muscle mass in patients with squamous cell carcinoma of the head and neck locally advanced (stage III-IVb) to assess that supplementation with EPA can maintain muscle mass along the oncologic treatment. Other aims are to evaluate the nutritional status, acute and chronic toxicities related with the loss of muscle mass and the impact of the EPA supplementation on overall and disease-free survival.

Conditions

• Squamous Cell Carcinoma of Head and Neck

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	EPA supplementation	2.7 g EPA supplementation in a 15 cc emulsion stick-pack
OTHER	Placebo	placebo in 15 cc emulsion stick-pack

Timeline

• Start date: 2015-12-23
• Primary completion: 2019-03-01
• Completion: 2019-09-02
• First posted: 2016-03-22
• Last updated: 2019-09-04

Locations

1 site across 1 country: Spain